33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CodeBreak 100: Phase I study of AMG 510, a novel KRAS(G12C) inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC)
    Meeting Abstract

    Hong, D. S.; Kuo, J.; Sacher, A. G.; Barlesi, F.; Besse, B.; Kuboki, Y.; Dy, G. K.; Dembla, V.; Krauss, J. C.; Burns, T. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Neuroleptic rotation for refractory agitation in cancer patients with delirium in the acute palliative care unit: A double-blind randomized clinical trial
    Meeting Abstract

    Hui, D.; De La Rosa, A.; Wilson, A.; Nguyen, T.; Wu, J.; Guay, M. D.; Azhar, A.; Arthur, J. A.; Epner, D. E.; Haider, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Interrogation of neoantigen-specific CD8 T cells in peripheral blood following PD-L1 blockade in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Holm, J. S.; Funt, S. A.; Bjerregaard, A. M.; Reading, J. L.; Maher, C. A.; Regazzi, A. M.; Wong, P.; Al-Ahmadie, H.; Overgaard, N. H.; Tamhane, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of CEP72 rs924607 with vincristine-induced peripheral neuropathy (PN) in patients with diffuse large B-cell lymphoma on CALGB 50303 (Alliance)
    Meeting Abstract

    Hertz, D. L.; Larson, N. B.; Pierpont, T.; Bartlett, N. L.; Zelenetz, A. D.; Wilson, W. H.; Leonard, J. P.; Jung, S. H.; Riska, S. M.; Richards, K. L.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary activity of tipifarnib in tumors of the head and neck, salivary gland and urothelial tract with HRAS mutations
    Meeting Abstract

    Ho, A. L.; Hanna, G. J.; Scholz, C. R.; Gualberto, A.; Park, S. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of tumor mutations with arterial thromboembolism risk in patients with solid cancer
    Meeting Abstract

    Ho, K. W.; Gupta, D.; Bolton, K. L.; Dunbar, A. J.; Willeit, P.; Soff, G. A.; Jee, J.; Zehir, A.; Bryce, Y.; Sidlow, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The nature and management of acquired resistance to PD1-based therapy in melanoma
    Meeting Abstract

    Hepner, A.; Versluis, J. M.; Gerard, C. L.; Brown, L. J.; Wallace, R.; Bhave, P.; Jansen, Y.; Klein, O.; Warner, A. B.; Mangana, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genetic testing experiences and emotional reactions among individuals with variant of uncertain significance results from cancer multiplex genetic testing
    Meeting Abstract

    Hamilton, J. G.; Brower, J.; Clark, D.; Ebrahimzadeh, J. E.; Kane, S. R.; Sanchez, P.; Wildman, T.; Merrill, M.; Couch, F.; Garber, J. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    Heinrich, M. C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II International Thyroid Oncology Group trial
    Meeting Abstract

    Haugen, B.; French, J.; Worden, F. P.; Konda, B.; Sherman, E. J.; Dadu, R.; Gianoukakis, A. G.; Wolfe, E. G.; Foster, N. R.; Bowles, D. W.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save